Background: The incidence of postoperative complications is high in lung cancer patients with renal dysfunction, and their long-term outcomes are poor.
Methods: From January 2015 to December 2017, 268 patients who underwent surgical resection for clinical stage I-IIIA non-small cell lung cancer (NSCLC) were included in this study. The 244 patients with serum creatinine (Cre) levels of <1.5 mg/dL were assigned to the control (CT) group, 11 patients with serum Cre levels of ≥1.5 mg/dL who were not on hemodialysis were assigned to the renal dysfunction (RD) group, and 13 patients on dialysis were assigned to the hemodialysis (HD) group.
Results: The mean ages in the CT, RD, and HD groups were 68.6±9.9 years, 70.5±11.4 years, and 68.8±9.9 years, respectively, with no statistically significant difference among them. There were no significant differences in perioperative outcomes. The 5-year relapse-free survival rates in the CT, RD, and HD groups were 74.19%, 90.00%, and 75.52%, respectively, while the corresponding 5-year overall survival rates were 88.29%, 71.43%, and 76.15%, respectively, with no statistically significant differences among them.
Conclusion: This study indicates that surgical treatment should be considered for NSCLC patients with renal dysfunction.
View full abstract